Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study

ConclusionsThis study documented real-world prophylactic and therapeutic AFMT use for IA/IM and associated outcomes among hospitalized patients in the USA since approval of isavuconazole. IA/IM were associated with lengthy hospital stays commonly requiring intensive care. Prophylactic and therapeutic AFMT dosages and duration generally followed recommendations and switching between agents was rare.FundingAstellas Pharma Global Development, Inc., Northbrook, IL, USA.

http://link.springer.com/10.1007/s40121-019-00267-4

Source: Infectious Diseases and Therapy - October 8, 2019 Category: Infectious Diseases Source Type: research